Taking the emotion out the discussions. I am loading up on $OBMP when can and being patient. After doing D&D this is why I believe the SP is a steal at anything below .10 and bargain basement right now. Albeit you’ll have to wait for the fruit to ripen before harvest.
Key D&D points
1. 4+ patents
2. Successful phase 1a, FDA allowed them to skip 1b go straight to phase 2.
3. Phase 2 plan discussed in 2016 meeting during phase 1 progress presentation. $OBMP Is tracking according to plan and the players laid out 2 years ago. Harvard Medical, UCNT etc. Clearly well throughout executions
4. In 2016, 10.1 Million share purchase agreement to fund phase 2 by Lincoln Capital already In place.
5. Working with FDA to get accelerated pathways to market (breakthrough therapy, Orphan Drug and fast track) for ProscaVax
6. Gardner insights Research 3/6/18 Prostate Specific Antigen Market Study showing $OBMP as one of the major players in this market.
7. In the pipeline after ProscaVax is immunization drug targeting ovarian cancer $$$$
8. $45 billion market size and growing in size to over $119B
9. Big Pharma also chasing solutions as well, and $OBMP owns unique patents and showing great success so far.
So I think with successful phase 2, it’ll go quickly to Phase 3 one of the most expensive but the most important phase where from here it goes for FDA approval. Given their proactivity preparing for phase 2, two years in advance, I would not be surprised if they were already in discussions with them FDA getting this laid out as well.
I believe with successful phase 2 you’ll see tremendous increases in SP continuing through phase 3 to market.
At least that’s my 2 cents. Hope you find this information useful.
